Protein Tyrosine Kinases, , MAP Kinase JNK1 Provide an Early Signal Required for Upregulation of Fas Ligand Expression in Aburatubolactam C-Induced Apoptosis of Human Jurkat T Cells |
BAE MYUNG AE
(Laboratory of Immunobiology, Department of Microbiology, College of Natural Sciences, Kyungpook National University, Current address: Laboratory of Molecular Pharmacology and Physiology, Bio-Medicinal Science Division, Korea Research Institute of Chemical Technology)
JUN DO YOUN (Institute for Genetic Engineering, Kyungpook National University) KIM KYUNG MIN (Institute for Genetic Engineering, Kyungpook National University) KIM SANG KOOK (Institute for Genetic Engineering, Kyungpook National University) CHUN JANG SOO (Department of Life Science, Kwangju Institute of Science and Technology) TAUB DENNIS (Laboratory of Immunobiology, Gerontology Research Centerer) PARK WAN (Laboratory of Immunobiology, Department of Microbiology, College of Natural Sciences, Kyungpook National University) MOON BYUNG-JO (Department of Biochemistry, College of Natural Sciences, Kyungpook National University) KIM YOUNG HO (Laboratory of Immunobiology, Department of Microbiology, College of Natural Sciences, Kyungpook National University) |
1 | Bae, M. A., H. S. Kang, S. W. Rue, J. H. Seu, and Y. H. Kim. 1998. Enhanced expression of Fas ligand is associated with aburatubolactam C-induced apoptosis in human Jurkat T cells. Biochem. Biophys. Res. Commun. 246: 276-281 DOI ScienceOn |
2 | Green, D. R., N. Droin, and M. Pinkoski. 2003. Activationinduced cell death in T cells. Immunol. Rev. 193: 70-81 DOI ScienceOn |
3 | Herr, I. and K. M. Debatin. 2001 Cellular stress response and apoptosis in cancertherapy. Blood 98: 2603-2614 DOI ScienceOn |
4 | Park, H. W., D. Y. Jun, and Y. H. Kim. 2002. Apoptotic activity of insect pathogenic fungus Paecilomyces japonica toward human acute leukemia Jurkat T cells is associated with mitochondria-dependent caspase-3 activation regulated by bcl-2. J. Microbial. Biatechnal. 12: 950-956 |
5 | Krueger, A., S. C. Fas, S. Baumann, and P. H. Krammer. 2003. The role of CD95 in the regulation of peripheral T-cell apoptosis.lmmunol. Rev. 193: 58-69 |
6 | Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. TomaselIi, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-l/Fas) signaling pathways. EMBO J. 17: 1675-1687 DOI ScienceOn |
7 | Tsutsumi, A. T., M. Kubo, H. Fujii, J. Freire-Moar, C. W. Turck, and J. T. Ransom. 1993. Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma celIs. J. Immunol. 150: 1746-1754 |
8 | Tudor, G, A. Aguilera, D. O. Halverson, N. D. Laing, and E. A. Sausville. 2000. Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bel-2 and Bel-xL protein levels. Cell Death Differ. 7: 574-586 DOI ScienceOn |
9 | Wilson, D. J., K. A. Fortner, D. H. Lynch, R. R. Mattingly, J. G. Macara, J. A. Posada, and R. C. Budd. 1996. INK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur. J. Immunol. 26: 989-994 DOI ScienceOn |
10 | Zhuang, S., M. C. Lynch, and I. E. Kochevar. 1998. Activation of protein kinase C is required for protection of celIs against apoptosis induced by singlet oxygen. FEBS Lett. 437: 158-162 DOI PUBMED ScienceOn |
11 | Liu, B. and Z. Fan. 2001. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway. Oncogene 20: 3726-3734 DOI ScienceOn |
12 | Ashe, P. C. and M. O. Berry. 2003. Apoptotic signaling cascades. Prog. Neuropsychopharmacol. Biol. Psychiatry 27: 199-214 |
13 | Pahlavani, M. A. 1998. T cell signaling: Effect of age. Front. Biosc. 3: 1120-1133 DOI |
14 | Widmann, C., S. Gibson, M. B. Jarpe, and G. Johnson. 1999. Mitogen-activated protein kinase: Conservation of a threekinase module from yeast to human. Physiol. Rev. 79: 143-180 DOI |
15 | Bae, M. A., K. Yamada, Y. !juin, T. Tsuji, and K. Yazawa. 1996. Aburatubolactam A, a novel inhibitor of superoxide anion generation from a marine microorganism. Heterocyclic Commun. 2: 315-318 |
16 | Bae, M. A., K. Yamada, O. Uemura, J. H. Seu, and Y. H. Kim. 1998. Aburatubolatam C, a novel apoptosis-inducing substance produced by marine Streptomyces sp. SCRC A-20. J. Microbiol. Biotech. 8: 455-460 |
17 | Muller, M., S. Strand, H. Hug, E. M. Heinemann, H. Walczak, W. J. Hofmann, W. Stremmel, P. H. Krammer, and P. R. Galle. 1997. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-I/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99: 403-413 DOI ScienceOn |
18 | Cascino, I., G. Papoff., R. De Maria, R. Testi, and G. Ruberti. 1996. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protect tumor cells from Fas-mediated apoptosis. J. Immunol. 156: 13-17 |
19 | Eischen, C. M., B. L. Williams, W. Zhang, L. E. Samelson, E. H. Lynch, R. T. Abraham, and P. J. Leibson. 1997. ZAP tyrosine kinase is required for the up-regulation of FAS ligand in activation-induced T cell apoptosis. J. Immunol. 159: 1135-1139 |
20 | Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462 DOI PUBMED ScienceOn |
21 | Shen, L., A. C. T. Liang, L. Lu, W. Y Au, Y. L. Kwong, R. H. S. Liang, and G. Srivastava. 2002. Frequent deletion of Fas gene sequence encoding death and transmembrane domains in nasal natural kilIer/T-celI lymphoma. Am. J. Pathol. 161: 2123-2131 DOI ScienceOn |
22 | Eichhorst, S. T., M. Muller, M. Li-Weber, H. SchulzeBergkamen, P. Angel, and P. H. Krammer. 2000. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol. Cell. Biol. 20: 7826-7837 DOI ScienceOn |
23 | VilIalba, M., S. Kasibhatla, L. Genestier, A. Mahboubi, D. R. Green, and A. Altman. 1999. Protein kinase C theta cooperates with calcineurin to induce Pas ligand expression during activation-induced T cell death. J. lmmunol. 163: 5813-5819 |
24 | Hyer, M. L., C. Voelkel-Johnson, S. Rubinchik, J. Dong, and J. S. Norris. 2000. Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis. Mol. Ther. 2: 348-358 DOI ScienceOn |
25 | Jarvis, W. D., K. L. Auer, M. Spector, G Kunos, S. Grant, P. Hylemon, R. Mikkelsen, and P. Dent. 1997. Positive and negative regulation of JNKI by protein kinase C and p42 MAP kinase in adult rat hepatocytes. FEBS Lett. 412: 9-14 DOI ScienceOn |
26 | Izquierdo, M., J. J. Leevers, C. J. Marshall, and D. Cantrell. 1993. couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes. J. Exp. Med. 178: 1199-1208 DOI ScienceOn |
27 | Friesen, C., J. Herr, P. H. Krammer, and K. M. Debatin. 1996. Involvement of the CD95 (APO-I/FAS) receptorl ligand system in drug-induced apoptosis in leukemia cells. Nature Med. 2: 574-578 DOI ScienceOn |
28 | Kim, Y. H., M. J. Buchholz, and A. A. Nordin. 1993. Murine T-Iymphocyte proliferation induced by interleukin 2 correlates with a transient increase in kinase activity and the tyrosine phosphorylation of a 97-kDa protein. Proc. Natl. Acad. Sci. USA 90: 3187-3191 |
29 | Nagarkatti, N. and B. A. Davis. 2003. Tamoxifen induces apoptosis in Fas+ tumor cells by upregulating the expression of Fas ligand. Cancer Chemother. Phamarcol. 51: 284-290 |
30 | Ramoneda, B. M. and R. Perez-Tomas. 2002. Activation of protein kinase C for protection of celIs against apoptosis induced by the immunosuppressor prodigiosin. Biochem. Pharmacol. 63: 463-469 DOI ScienceOn |
31 | Shimizu, S., Y. Eguchi, H. Kosaka, W. Kamiike, H. Matsuda, and Y. Tsujimoto. 1995. Prevention of hypoxia-induced cell death by Bel-2 and Bel-xL. Nature 374: 811-813 DOI ScienceOn |
32 | Oyaizu, N., S. Than, T. W. McCloskey, and S. Pahwa. 1995. Requirement of in T-cell receptor/CD3 mediated apoptosis and Fas-ligand induction in Jurkat T cells. Biochem. Biophys. Res. Commun. 213: 994-1001 DOI PUBMED ScienceOn |
33 | Chang, S. H., C. O. Oh, M. S. Yang, S. S. Kang, Y. S. Lee, J. K. Sonn, and J. S. Chun. 1998. Protein kinase C regulates chondrogenesis of mesenchymes via mitogen-activated protein kinase signaling. J. Biol. Chem. 273: 19213 -19219 DOI ScienceOn |
34 | Datta, R., Y. Manome, N. Taneja, L. H. Boise, R. Weichselbaum, C. B. Thompson, C. A. Slapak, and D. Kufe. 1995. Overexpression of Bel- XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced interriucleosomal DNA fragmentation. Cell Growth Differ. 6: 363-370 |
35 | Atkinson, E. A., H. Ostergaard, K. Kane, M. J. Pinkoski, A. Caputo, M. W. Olszowy, and R. C. Bleackley. 1996. A physical interaction between the cell death protein Fas and the tyrosine kinase . J. Biol. Chem. 271: 5968-5971 DOI |
36 | Faris, M., N. Kokot, K. Latinis, S. Kasibhatla, O. R. Green, G. A. Koretzky, and A. Nel. 1998. The c-jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by upregulating Fas ligand expression. J. Immunol. 160: 134-144 |
37 | Lamy, T., J. H. Liu, T. H. Landowski, W. S. Dalton, and T. P. Loughran Jr. 1998. Dysregulation of CD95/CD95 ligandapoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 92: 4771-4777 |
38 | Stadheim, T. A. and G. L. Kusera. 1998. ExtracelIular signalregulated kinase (ERK) activity is required for TPAmediated inhibition of drug-induced apoptosis. Biochem. Biophys. Res. Commun. 245: 266-271 DOI ScienceOn |
39 | Veillette, A., L D. Horak, E. M. Horak, M. A. Bookman, and J. B. Bolen. 1988. Alterations of the lymphocyte-specific protein tyrosine kinase ( ) during T-ceII activation. Mol. Cell. Biol. 8: 4353-4361 DOI |
40 | Zhu, L., X. Yu, Y. Akatsuka, J. A. Cooper, and C. Anasetti. 1999. Role of mitogen-activated protein kinases in activationinduced apoptosis of T cells. Immunology 97: 26-35 DOI ScienceOn |
41 | Simonian, P. L., D. A. Grillot, and G. Nunez. 1997. BeI-2 and Bel-xL can differentially block chemotherapy-induced cell death. Blood 90: 1208-1216 |
42 | Hannun, Y. A. 1997. Apoptosis and dilemma of cancer chemotheraphy. Blood 89: 1845-1853 |